Income Statement (TTM)
Cardiff Oncology, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
| Change (%) | 7.78 | 1.09 | 7.03 | -12.88 | 4.06 | 0.56 | 6.37 | 1.82 | -1.28 | 2.33 | 4.30 | 11.65 | 6.09 | 25.00 | 9.02 | 3.46 | -0.73 | -14.06 | -7.16 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 11 | 11 | 12 | 13 | 15 | 17 | 21 | 25 | 26 | 27 | 29 | 30 | 32 | 33 | 32 | 33 | 35 | 37 | 39 | 41 |
| Change (%) | 3.07 | 5.10 | 13.92 | 9.66 | 17.80 | 22.61 | 15.63 | 7.53 | 2.33 | 6.80 | 1.98 | 6.82 | 4.19 | -3.18 | 4.63 | 4.86 | 5.58 | 6.70 | 5.31 | |
| % of Revenue | 3,210.01 | 3,069.67 | 3,191.35 | 3,396.97 | 4,275.65 | 4,840.11 | 5,901.66 | 6,415.10 | 6,774.68 | 7,022.54 | 7,329.37 | 7,165.78 | 6,855.65 | 6,732.99 | 5,215.25 | 5,005.41 | 5,073.11 | 5,395.61 | 6,698.64 | 7,597.80 |
| Gross Operating Profit | -11 | -11 | -11 | -13 | -14 | -17 | -21 | -24 | -26 | -27 | -29 | -29 | -31 | -32 | -31 | -33 | -34 | -36 | -39 | -41 |
| Change (%) | 2.92 | 5.24 | 14.15 | 10.34 | 18.12 | 23.08 | 15.78 | 7.62 | 2.39 | 6.87 | 1.94 | 6.75 | 4.16 | -3.60 | 4.54 | 4.89 | 5.71 | 7.09 | 5.50 | |
| % of Revenue | -3,110.02 | -2,969.67 | -3,091.35 | -3,296.97 | -4,175.65 | -4,740.11 | -5,801.66 | -6,315.10 | -6,674.68 | -6,922.54 | -7,229.37 | -7,065.78 | -6,755.65 | -6,632.99 | -5,115.25 | -4,905.41 | -4,973.11 | -5,295.61 | -6,598.64 | -7,497.80 |
| SG&A | 6 | 8 | 9 | 10 | 11 | 12 | 14 | 14 | 14 | 13 | 12 | 14 | 13 | 13 | 13 | 12 | 12 | 12 | 13 | 13 |
| Change (%) | 30.07 | 9.12 | 13.04 | 12.68 | 3.66 | 14.40 | 1.83 | 1.07 | -5.43 | -6.50 | 9.82 | -1.02 | -2.64 | 0.36 | -8.26 | 1.56 | 2.35 | 7.08 | 0.77 | |
| % of Revenue | 1,860.37 | 2,245.08 | 2,423.24 | 2,559.34 | 3,310.14 | 3,297.49 | 3,751.52 | 3,591.41 | 3,564.71 | 3,414.77 | 3,120.00 | 3,284.95 | 2,912.17 | 2,672.75 | 2,145.90 | 1,805.86 | 1,772.67 | 1,827.53 | 2,277.00 | 2,471.38 |
| R&D | ||||||||||||||||||||
| Change (%) | ||||||||||||||||||||
| % of Revenue | ||||||||||||||||||||
| OpEx | 17 | 19 | 21 | 24 | 26 | 29 | 35 | 38 | 40 | 40 | 41 | 43 | 45 | 46 | 45 | 45 | 47 | 49 | 53 | 55 |
| Change (%) | 12.98 | 6.80 | 13.54 | 10.96 | 11.63 | 19.29 | 10.26 | 5.21 | -0.34 | 2.45 | 4.32 | 4.35 | 2.15 | -2.17 | 0.87 | 3.98 | 4.75 | 6.80 | 4.16 | |
| % of Revenue | 5,070.39 | 5,314.75 | 5,614.59 | 5,956.31 | 7,585.80 | 8,137.60 | 9,653.19 | 10,006.51 | 10,339.39 | 10,437.31 | 10,449.37 | 10,450.73 | 9,767.83 | 9,405.74 | 7,361.15 | 6,811.28 | 6,845.78 | 7,223.13 | 8,975.64 | 10,069.17 |
| Operating Income | -17 | -19 | -20 | -23 | -26 | -29 | -34 | -38 | -40 | -40 | -41 | -43 | -44 | -45 | -44 | -45 | -46 | -49 | -52 | -54 |
| Change (%) | 13.08 | 6.91 | 13.66 | 11.36 | 11.73 | 19.52 | 10.31 | 5.24 | -0.33 | 2.45 | 4.32 | 4.28 | 2.11 | -2.46 | 0.76 | 3.99 | 4.83 | 7.09 | 4.28 | |
| % of Revenue | -4,970.39 | -5,214.75 | -5,514.59 | -5,856.31 | -7,485.80 | -8,037.60 | -9,553.19 | -9,906.51 | -10,239.39 | -10,337.31 | -10,349.37 | -10,350.73 | -9,667.83 | -9,305.74 | -7,261.15 | -6,711.28 | -6,745.78 | -7,123.13 | -8,875.64 | -9,969.17 |
| Interest Expense | -0 | -0 | -0 | -0 | ||||||||||||||||
| Change (%) | -0.00 | -0.00 | -0.00 | |||||||||||||||||
| % of Revenue | -0.55 | -0.54 | -0.51 | -0.58 | ||||||||||||||||
| Net Income | -17 | -19 | -20 | -23 | -25 | -28 | -34 | -38 | -39 | -39 | -39 | -40 | -41 | -41 | -40 | -41 | -43 | -45 | -49 | -51 |
| Change (%) | 13.89 | 5.65 | 12.91 | 10.49 | 11.18 | 20.55 | 10.81 | 4.39 | -1.89 | 0.59 | 1.82 | 2.93 | 1.57 | -2.92 | 1.56 | 5.20 | 5.70 | 7.53 | 4.43 | |
| % of Revenue | -4,992.25 | -5,275.14 | -5,512.70 | -5,815.66 | -7,375.65 | -7,880.50 | -9,447.37 | -9,841.41 | -10,089.26 | -10,026.94 | -9,856.71 | -9,621.60 | -8,869.78 | -8,492.01 | -6,594.92 | -6,143.91 | -6,247.24 | -6,651.68 | -8,322.66 | -9,361.28 |
Source: Capital IQ
